[{"address1": "4546 El Camino Real", "address2": "Suite B1", "city": "Los Altos", "state": "CA", "zip": "94022", "country": "United States", "phone": "650 284 4433", "fax": "650 397 4433", "website": "https://renovorx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer. The company has a research collaboration with Imugene Limited to deliver oncolytic virus therapy for the treatment of difficult-to-access tumors. RenovoRx, Inc. was founded in 2009 and is headquartered in Los Altos, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ramtin  Agah M.D.", "age": 58, "title": "Founder, Chairman of Board & Chief Medical Officer", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 332894, "exercisedValue": 0, "unexercisedValue": 173000}, {"maxAge": 1, "name": "Mr. Shaun R. Bagai", "age": 47, "title": "CEO, Secretary & Director", "yearBorn": 1977, "fiscalYear": 2023, "totalPay": 589376, "exercisedValue": 0, "unexercisedValue": 304200}, {"maxAge": 1, "name": "Mr. Robert  Strasser", "title": "Vice President of Operations and R&D", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ronald B. Kocak CPA, CGMA", "age": 67, "title": "VP, Controller & Principal Accounting Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leesa  Gentry", "age": 54, "title": "Chief Clinical Officer", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ryan  Witt", "title": "Senior VP and Head of Corporate Strategy & Partnerships", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.02, "open": 1.07, "dayLow": 1.0, "dayHigh": 1.07, "regularMarketPreviousClose": 1.02, "regularMarketOpen": 1.07, "regularMarketDayLow": 1.0, "regularMarketDayHigh": 1.07, "payoutRatio": 0.0, "beta": 1.152, "forwardPE": -2.4390244, "volume": 25848, "regularMarketVolume": 25848, "averageVolume": 138486, "averageVolume10days": 99320, "averageDailyVolume10Day": 99320, "bid": 0.7416, "ask": 1.29, "bidSize": 1, "askSize": 1, "marketCap": 35565300, "fiftyTwoWeekLow": 0.774, "fiftyTwoWeekHigh": 1.69, "fiftyDayAverage": 1.13218, "twoHundredDayAverage": 1.143115, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14438339, "profitMargins": 0.0, "floatShares": 23693162, "sharesOutstanding": 35565300, "sharesShort": 189155, "sharesShortPriorMonth": 205910, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0053, "heldPercentInsiders": 0.01286, "heldPercentInstitutions": 0.02852, "shortRatio": 1.95, "shortPercentOfFloat": 0.0054, "impliedSharesOutstanding": 36960000, "bookValue": 0.295, "priceToBook": 3.3898306, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -9163000, "trailingEps": -0.58, "forwardEps": -0.41, "52WeekChange": -0.24242425, "SandP52WeekChange": 0.06429911, "quoteType": "EQUITY", "currentPrice": 1.0, "targetHighPrice": 9.0, "targetLowPrice": 3.0, "targetMeanPrice": 4.875, "targetMedianPrice": 3.75, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 9563000, "totalCashPerShare": 0.398, "totalDebt": 0, "quickRatio": 5.397, "currentRatio": 5.661, "returnOnAssets": -0.93311995, "returnOnEquity": -2.58952, "freeCashflow": -5186875, "operatingCashflow": -8748000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "RNXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1629984600000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.0, "postMarketChange": 0.0, "regularMarketChange": -0.01999998, "regularMarketDayRange": "1.0 - 1.07", "shortName": "RenovoRx, Inc.", "longName": "RenovoRx, Inc.", "marketState": "CLOSED", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 138486, "fiftyTwoWeekLowChange": 0.22600001, "fiftyTwoWeekLowChangePercent": 0.29198968, "fiftyTwoWeekRange": "0.774 - 1.69", "fiftyTwoWeekHighChange": -0.69000006, "fiftyTwoWeekHighChangePercent": -0.40828404, "fiftyTwoWeekChangePercent": -24.242424, "earningsTimestampStart": 1743537600, "earningsTimestampEnd": 1743969600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.58, "epsForward": -0.41, "epsCurrentYear": -0.405, "priceEpsCurrentYear": -2.4691358, "fiftyDayAverageChange": -0.13217998, "fiftyDayAverageChangePercent": -0.1167482, "twoHundredDayAverageChange": -0.14311504, "twoHundredDayAverageChangePercent": -0.12519741, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-08-26", "averageAnalystRating": "1.5 - Strong Buy", "cryptoTradeable": false, "regularMarketChangePercent": -1.9607825, "regularMarketPrice": 1.0, "corporateActions": [], "postMarketTime": 1743199560, "regularMarketTime": 1743192001, "exchange": "NCM", "messageBoardId": "finmb_236111504", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "RenovoRx", "trailingPegRatio": null, "__fetch_time": "2025-03-29"}]